233 related articles for article (PubMed ID: 19795384)
1. Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes.
Frost RA; Huber D; Pruznak A; Lang CH
J Cell Biochem; 2009 Dec; 108(5):1192-202. PubMed ID: 19795384
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms.
Li BG; Hasselgren PO; Fang CH
Int J Biochem Cell Biol; 2005 Oct; 37(10):2207-16. PubMed ID: 15927518
[TBL] [Abstract][Full Text] [Related]
3. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids.
Shen WH; Boyle DW; Wisniowski P; Bade A; Liechty EA
J Endocrinol; 2005 May; 185(2):275-89. PubMed ID: 15845920
[TBL] [Abstract][Full Text] [Related]
4. Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.
Quinn LS; Anderson BG; Plymate SR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1538-51. PubMed ID: 17940216
[TBL] [Abstract][Full Text] [Related]
5. Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle.
White JP; Gao S; Puppa MJ; Sato S; Welle SL; Carson JA
Mol Cell Endocrinol; 2013 Jan; 365(2):174-86. PubMed ID: 23116773
[TBL] [Abstract][Full Text] [Related]
6. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
7. Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes.
Miyazaki M; McCarthy JJ; Esser KA
FEBS J; 2010 May; 277(9):2180-91. PubMed ID: 20412061
[TBL] [Abstract][Full Text] [Related]
8. Ethyl pyruvate preserves IGF-I sensitivity toward mTOR substrates and protein synthesis in C2C12 myotubes.
Frost RA; Pereyra E; Lang CH
Endocrinology; 2011 Jan; 152(1):151-63. PubMed ID: 21106878
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
[TBL] [Abstract][Full Text] [Related]
10. Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats.
Sheriff S; Kadeer N; Joshi R; Friend LA; James JH; Balasubramaniam A
Mol Cell Endocrinol; 2012 Apr; 351(2):286-95. PubMed ID: 22266196
[TBL] [Abstract][Full Text] [Related]
11. Protective Effect of
Lee MK; Choi JW; Choi YH; Nam TJ
Mar Drugs; 2019 May; 17(5):. PubMed ID: 31083497
[TBL] [Abstract][Full Text] [Related]
12. Acute alcohol intoxication increases REDD1 in skeletal muscle.
Lang CH; Frost RA; Vary TC
Alcohol Clin Exp Res; 2008 May; 32(5):796-805. PubMed ID: 18336631
[TBL] [Abstract][Full Text] [Related]
13. REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss.
Wu Y; Zhao W; Zhao J; Zhang Y; Qin W; Pan J; Bauman WA; Blitzer RD; Cardozo C
Endocrinology; 2010 Mar; 151(3):1050-9. PubMed ID: 20032058
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone stimulates protein synthesis in bovine skeletal muscle cells without altering insulin-like growth factor-I mRNA expression.
Ge X; Yu J; Jiang H
J Anim Sci; 2012 Apr; 90(4):1126-33. PubMed ID: 22100600
[TBL] [Abstract][Full Text] [Related]
15. Divergent regulation of insulin-like growth factor binding protein genes in cultured Atlantic salmon myotubes under different models of catabolism and anabolism.
Garcia de la Serrana D; Fuentes EN; Martin SAM; Johnston IA; Macqueen DJ
Gen Comp Endocrinol; 2017 Jun; 247():53-65. PubMed ID: 28109823
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I blocks dexamethasone-induced protein degradation in cultured myotubes by inhibiting multiple proteolytic pathways: 2002 ABA paper.
Li BG; Hasselgren PO; Fang CH; Warden GD
J Burn Care Rehabil; 2004; 25(1):112-8. PubMed ID: 14726748
[TBL] [Abstract][Full Text] [Related]
17. IGF-I activates the mouse type IIb myosin heavy chain gene.
Shanely RA; Zwetsloot KA; Childs TE; Lees SJ; Tsika RW; Booth FW
Am J Physiol Cell Physiol; 2009 Oct; 297(4):C1019-27. PubMed ID: 19657059
[TBL] [Abstract][Full Text] [Related]
18. IGF-1 Attenuates Hypoxia-Induced Atrophy but Inhibits Myoglobin Expression in C2C12 Skeletal Muscle Myotubes.
Peters EL; van der Linde SM; Vogel ISP; Haroon M; Offringa C; de Wit GMJ; Koolwijk P; van der Laarse WJ; Jaspers RT
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28862673
[TBL] [Abstract][Full Text] [Related]
19. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals.
Zhang D; Bar-Eli M; Meloche S; Brodt P
J Biol Chem; 2004 May; 279(19):19683-90. PubMed ID: 14993222
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
